Vivo Capital, LLC Diversified Active

CIK: 0001674712 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 10, 2018

Total Value ($000): $776,070 (100.0% shares, 0.0% debt)

Holdings (40)

ASND Ascendis Pharma 18.6%

Value ($000) $144,138 Shares 2,166,832 Est. Cost $26.35 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd 10.4%

Value ($000) $80,998 Shares 2,049,545 Est. Cost $36.97 Unrealized —

— Kadmon Holdings (KDMN) 8.9%

Value ($000) $68,919 Shares 10,454,545 Est. Cost $5.56 Unrealized —

CDXS Codexis, Inc. 5.7%

Value ($000) $43,989 Shares 3,054,825 Est. Cost $3.85 Unrealized +238.3%

ACRS Aclaris Therapeutics 4.2%

Value ($000) $32,895 Shares 1,647,214 Est. Cost $19.11 Unrealized -3.3%

— Menlo Therapeutics 4.2%

Value ($000) $32,571 Shares 4,011,236 Est. Cost $37.58 Unrealized —

APLS Apellis Pharmaceuticals, Inc. 4.1%

Value ($000) $32,043 Shares 1,456,499 Est. Cost $14.72 Unrealized +56.1%

— Tricida, Inc. 3.8%

Value ($000) $29,652 Shares 991,711 Est. Cost $29.90 Unrealized —

— Homology Medicines, Inc. 3.7%

Value ($000) $28,759 Shares 1,409,742 Est. Cost $19.00 Unrealized —

— MEI Pharma Inc (NAS) 3.4%

Value ($000) $26,007 Shares 6,600,660 Est. Cost $3.94 Unrealized —

ARWR Arrowhead Pharmaceuticals In 3.3%

Value ($000) $25,840 Shares 1,900,000 Est. Cost $6.16 Unrealized +51.8%

— Eiger BioPharmaceuticals 2.8%

Value ($000) $21,853 Shares 1,791,257 Est. Cost $16.42 Unrealized —

— Amyris, Inc. 2.3%

Value ($000) $18,063 Shares 2,826,711 Est. Cost $3.20 Unrealized —

MDGL Madrigal Pharmaceuticals Inc 2.2%

Value ($000) $17,402 Shares 62,220 Est. Cost $152.78 Unrealized +14.9%

— Kala Pharmaceuticals, Inc. 1.8%

Value ($000) $14,321 Shares 1,043,020 Est. Cost $22.84 Unrealized —

— Nabriva Therapeutics Plc 1.8%

Value ($000) $14,178 Shares 4,074,190 Est. Cost $8.19 Unrealized —

— Obseva SA 1.8%

Value ($000) $14,005 Shares 925,000 Est. Cost $15.14 Unrealized —

— Cymabay Therapeutics inc 1.6%

Value ($000) $12,158 Shares 906,000 Est. Cost $13.04 Unrealized —

— Strongbridge Biopharma plc 1.5%

Value ($000) $11,509 Shares 1,918,132 Est. Cost $2.40 Unrealized —

— Selecta Biosciences, Inc. 1.3%

Value ($000) $10,343 Shares 780,601 Est. Cost $19.86 Unrealized —

— Soleno Therapeutics, Inc. 1.3%

Value ($000) $10,202 Shares 4,359,683 Est. Cost $1.84 Unrealized —

— Deciphera Pharmaceuticals In 1.3%

Value ($000) $9,953 Shares 252,942 Est. Cost $39.35 Unrealized —

— Galmed Pharmaceuticals Ltd 1.2%

Value ($000) $9,433 Shares 792,707 Est. Cost $11.90 Unrealized —

— Zymeworks Inc 1.2%

Value ($000) $9,166 Shares 620,134 Est. Cost $14.78 Unrealized —

— Sierra Oncology, Inc 0.9%

Value ($000) $7,217 Shares 2,438,270 Est. Cost $1.55 Unrealized —

— Genocea Biosciences Inc(NMS) 0.9%

Value ($000) $7,000 Shares 8,180,000 Est. Cost $1.05 Unrealized —

AUPH Aurinia Pharmaceuticals Inc. 0.9%

Value ($000) $6,831 Shares 1,213,290 Est. Cost $5.62 Unrealized -0.7%

RGNX Regenxbio Inc. 0.8%

Value ($000) $5,912 Shares 82,403 Est. Cost $12.80 Unrealized +273.1%

ZLAB Zai Lab LTD 0.7%

Value ($000) $5,371 Shares 231,010 Est. Cost $27.00 Unrealized —

— Zogenix, Inc. 0.6%

Value ($000) $4,641 Shares 105,000 Est. Cost $40.05 Unrealized —

— Foamix Pharmaceuticals Ltd. 0.6%

Value ($000) $4,284 Shares 855,000 Est. Cost $9.26 Unrealized —

— BioPharmX Corporation 0.5%

Value ($000) $3,561 Shares 16,128,515 Est. Cost $0.36 Unrealized —

— Kiniksa Pharmaceuticals-A 0.4%

Value ($000) $3,228 Shares 186,073 Est. Cost $17.35 Unrealized —

— Verona Pharma Plc 0.4%

Value ($000) $2,792 Shares 1,492,951 Est. Cost $13.61 Unrealized —

— Trevena, Inc. 0.3%

Value ($000) $2,488 Shares 1,728,000 Est. Cost $7.67 Unrealized —

KALV KalVista Pharmaceuticals, Inc. 0.3%

Value ($000) $2,439 Shares 300,325 Est. Cost $7.13 Unrealized +23.9%

— Agile Therapeutics, Inc. 0.1%

Value ($000) $742 Shares 1,513,975 Est. Cost $6.21 Unrealized —

— Akari Therapeutics Plc 0.1%

Value ($000) $674 Shares 345,850 Est. Cost $14.00 Unrealized —

— Sunesis Pharmaceuticals, Inc. 0.1%

Value ($000) $414 Shares 195,474 Est. Cost $3.62 Unrealized —

— Soleno Therapeutics, Inc. 0.0%

Value ($000) $79 Shares 188,772 Est. Cost $0.14 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ASND	Ascendis Pharma	2,166,832	$144,138	18.6%	$26.35	—	ADR	04351P101
—	Biohaven Pharmaceutical Holding Company Ltd	2,049,545	$80,998	10.4%	$36.97	—	Common	G11196105
—	Kadmon Holdings (KDMN)	10,454,545	$68,919	8.9%	$5.56	—	Common	48283N106
CDXS	Codexis, Inc.	3,054,825	$43,989	5.7%	$3.85	+238.3%	Common	192005106
ACRS	Aclaris Therapeutics	1,647,214	$32,895	4.2%	$19.11	-3.3%	Common	00461U105
—	Menlo Therapeutics	4,011,236	$32,571	4.2%	$37.58	—	Common	586858102
APLS	Apellis Pharmaceuticals, Inc.	1,456,499	$32,043	4.1%	$14.72	+56.1%	Common	03753U106
—	Tricida, Inc.	991,711	$29,652	3.8%	$29.90	—	Common	89610F101
—	Homology Medicines, Inc.	1,409,742	$28,759	3.7%	$19.00	—	Common	438083107
—	MEI Pharma Inc (NAS)	6,600,660	$26,007	3.4%	$3.94	—	Common	55279B202
ARWR	Arrowhead Pharmaceuticals In	1,900,000	$25,840	3.3%	$6.16	+51.8%	Common	04280A100
—	Eiger BioPharmaceuticals	1,791,257	$21,853	2.8%	$16.42	—	Common	28249U105
—	Amyris, Inc.	2,826,711	$18,063	2.3%	$3.20	—	Common	03236M200
MDGL	Madrigal Pharmaceuticals Inc	62,220	$17,402	2.2%	$152.78	+14.9%	Common	558868105
—	Kala Pharmaceuticals, Inc.	1,043,020	$14,321	1.8%	$22.84	—	Common	483119103
—	Nabriva Therapeutics Plc	4,074,190	$14,178	1.8%	$8.19	—	SHS	G63637105
—	Obseva SA	925,000	$14,005	1.8%	$15.14	—	Common	H5861P103
—	Cymabay Therapeutics inc	906,000	$12,158	1.6%	$13.04	—	Common	23257D103
—	Strongbridge Biopharma plc	1,918,132	$11,509	1.5%	$2.40	—	SHS USD	G85347105
—	Selecta Biosciences, Inc.	780,601	$10,343	1.3%	$19.86	—	Common	816212104
—	Soleno Therapeutics, Inc.	4,359,683	$10,202	1.3%	$1.84	—	Common	834203200
—	Deciphera Pharmaceuticals In	252,942	$9,953	1.3%	$39.35	—	Common	24344T101
—	Galmed Pharmaceuticals Ltd	792,707	$9,433	1.2%	$11.90	—	SHS	M47238106
—	Zymeworks Inc	620,134	$9,166	1.2%	$14.78	—	Common	98985W102
—	Sierra Oncology, Inc	2,438,270	$7,217	0.9%	$1.55	—	Common	82640U107
—	Genocea Biosciences Inc(NMS)	8,180,000	$7,000	0.9%	$1.05	—	Common	372427104
AUPH	Aurinia Pharmaceuticals Inc.	1,213,290	$6,831	0.9%	$5.62	-0.7%	Common	05156V102
RGNX	Regenxbio Inc.	82,403	$5,912	0.8%	$12.80	+273.1%	Common	75901B107
ZLAB	Zai Lab LTD	231,010	$5,371	0.7%	$27.00	—	ADR	98887Q104
—	Zogenix, Inc.	105,000	$4,641	0.6%	$40.05	—	Common	98978L204
—	Foamix Pharmaceuticals Ltd.	855,000	$4,284	0.6%	$9.26	—	SHS	M46135105
—	BioPharmX Corporation	16,128,515	$3,561	0.5%	$0.36	—	Common	09072X101
—	Kiniksa Pharmaceuticals-A	186,073	$3,228	0.4%	$17.35	—	Common	G5269C101
—	Verona Pharma Plc	1,492,951	$2,792	0.4%	$13.61	—	ADS	925050106
—	Trevena, Inc.	1,728,000	$2,488	0.3%	$7.67	—	Common	89532E109
KALV	KalVista Pharmaceuticals, Inc.	300,325	$2,439	0.3%	$7.13	+23.9%	Common	483497103
—	Agile Therapeutics, Inc.	1,513,975	$742	0.1%	$6.21	—	Common	00847L100
—	Akari Therapeutics Plc	345,850	$674	0.1%	$14.00	—	ADR	00972G108
—	Sunesis Pharmaceuticals, Inc.	195,474	$414	0.1%	$3.62	—	Common Par	867328700
—	Soleno Therapeutics, Inc.	188,772	$79	0.0%	$0.14	—	Warrant	834203135